key: cord-0309809-ts0ls7yl
authors: Grabherr, S.; Waltenspühl, A.; Lütge, M.; Büchler, L.; Cheng, H.W.; Zielińska, K.; Caviezel-Firner, S.; Krebs, P.; Ludewig, B.; Pikor, N.B.
title: TYPE I INTERFERON-DEPENDENT CELLULAR REMODELING DURING ACUTE PULMONARY MHV INFECTION
date: 2022-02-01
journal: bioRxiv
DOI: 10.1101/2022.02.01.478627
sha: 32de2a0c3f505f1c83b79438fa6708861d958821
doc_id: 309809
cord_uid: ts0ls7yl

Impaired type I interferon (IFN) responses are predictive of severe disease during pulmonary coronavirus infection. In the periphery, dampened IFN-responsiveness is associated with viremia and hypercytokinemia, however the resolution of IFN-dependent innate immune responses in the lungs remains limited. Here, we aimed to elucidate the early dynamics of antiviral immunity and define the IFN-dependent mechanisms limiting viral spread during pulmonary infection with the murine hepatitis virus (MHV), a beta-coronavirus. While several innate immune cell types infiltrated the lungs concomitant with viral replication, the influx of type I IFN-responsive myeloid cells was essential for viral containment and prevention of fatal disease. Combining high-resolution transcriptomic analysis and genetic attenuation of interferon signaling, we delineated IFN-dependent cell-intrinsic and population-based transcriptional changes that determined viral replication and inflammatory maturation, respectively. While monocyte-derived macrophages exhibited the strongest pro-inflammatory transcriptional reprogramming during pulmonary infection, these maturation programs were impaired in the absence of IFN-signalling. Instead, IFN-deficient monocyte-derived macrophages expressed genes encoding for neutrophil attractants and IL1β, resulting in enhanced lung injury. Our results reveal the requirement for type I IFN-induced antiviral states and inflammation-induced maturation programs to secure pulmonary viral containment.

Coronaviruses (CoVs) are enveloped, single-stranded RNA viruses that in humans primarily cause pulmonary infections 1, 2 . While the common cold CoVs are associated with mild respiratory symptoms, the emergence of pandemic strains including SARS-CoV-2 highlights the potential for CoVs to cause severe disease 3, 4 . Early studies revealed elevated pro-inflammatory serum cytokine levels and dysfunctional immune responses as clinical correlates of disease severity [5] [6] [7] [8] [9] [10] . Indicators of attenuated interferon (IFN) responses, including low serum levels of IFN-alpha (IFN-) and reduced interferon-stimulated gene (ISG) signatures in peripheral blood mononuclear cells and bronchoalveolar lavage leukocytes were soon observed to be associated with severe COVID-19 [11] [12] [13] [14] [15] [16] . Among patients with severe disease, genetic mutations in loci responsible for type I IFN production or responsiveness 17, 18 , as well as autoantibodies directed against type I IFNs 19 may in part explain the inverse correlation between IFN-associated signatures and disease outcome. Further mechanistic insight has been offered by transcriptomic studies of peripheral blood mononuclear cells that observed the concomitant activation of NFb signaling, which encodes a number of pro-inflammatory genes, in patients with severe COVID-19, dampened ISG signatures and viremia. Here, impaired type I IFN-mediated control of viral load, was suggested to lead to increased recognition of PAMPs and DAMPs, resulting in NFBmediated hypercytokinemia 11 . Nevertheless, longitudinal studies have primarily been performed on peripheral blood, and bronchoalveolar lavage sampling of incubated, intensive care patients that occurs days to weeks after initial innate IFN-mediated responses in the lungs. Thus, the cell types governing IFN-mediated viral containment in the lungs, as well as the concomitant local changes exacerbating pro-inflammatory gene signatures in the context of impaired IFN responsiveness remain elusive.

The mouse coronavirus (also known as the mouse hepatitis virus; MHV), like SARS-CoV-2, is a betacoronavirus. Studies using MHV have elucidated key cellular players in type I IFN production and responsiveness. Plasmacytoid dendritic cells (pDCs) are the first producers of type I IFN 20 . While many cell types respond to IFN signaling, type I IFN-α receptor (IFNAR) signaling in macrophages has been shown to critically contain viral spread 21 . While IFN responsiveness in myeloid-lineage cells preserves organ function following intraperitoneal infection, the requirement of IFNAR-signaling in this cell population during pulmonary MHV infection has not been examined. Studies of mouse-adapted human coronaviruses in gene-deficient mice have revealed contradicting results for the requirements of IFNAR-signaling in controlling viral titers 22, 23 , likely owing to different mutations acquired by viral passaging in different mouse strains.

Alternatively, other innate immune mechanisms may account for early viral containment in the lungs. In another mucosal tissue, NK cells have been shown to limit early MHV viral spread 24 . Collectively, the cellular and molecular pathways securing immediate early viral containment during pulmonary MHV infection warrant further investigation.

Here we employed the MHV model to systematically dissect the dynamics of viral spread and anti-viral immunity in mice. We observed that the ability of myeloid cells to sense type I interferons was crucial for the survival and containment of viral load in the lungs of MHV infected mice. Single-cell RNA sequencing of lungs from infected mice revealed dominant IFN-response and pro-inflammatory cytokine gene signatures in the myeloid cell compartment. To delineate early type I IFN-dependent changes in the immunological landscape during early MHV infection, we examined the transcriptional and cellular profile of lungs from Ifnar-proficient and Ifnar-deficient LysM-Cre-targeted mice. In mice unable to sense type I interferons, we found divergent regulation of pro-inflammatory cytokines and chemokines, more influx of neutrophils, interstitial pneumonia and signs of enhanced lung injury.

C57BL/6 (B6) mice were purchased from Charles River Laboratories and LysM-Cre mice were purchased from Jackson Laboratory. LysM-Cre Ifnar fl/fl mice were provided by U. Kalinke 

Mice were infected intranasally with 5x10 4 pfu MHV-A59 or MHV-GFP as previously described [26] [27] [28] .

Mice were observed daily and clinical disease symptoms and weights were noted. MHV titers were determined by standard plaque assay using L929 cells 20 .

B6 mice were injected with 0.5 mg/ml anti-NK1.1 antibody intra-peritoneal one day prior to infection with 5x10 4 PFU MHV. Depleting antibody was injected every second day after the first depletion.

Cell isolation from mouse lungs was performed according to standardized protocols 29 . Mice were euthanized at the indicated time points and immediately perfused with PBS. Lungs were transferred into a 6-well plate containing RPMI 1640 medium (Sigma-Aldrich) supplemented with 4U/ mL elastase (Worthington), 1U/ mL Dispase II (Roche) and 10 μl/mL DNAse I (Applichem) and incubated for 45 minutes at 37°C. Lung tissue was then mechanically disrupted and washed in cold RPMI. Tissues were subject to a second enzymatic digestion in RPMI 1640 medium supplemented with 25 μg/mL Liberase TM (Roche) and 0.25 μg/mL DNAse I and incubated for 30 minutes at 37 °C. Any larger tissue fragments were dissociated mechanically followed by washing of the cell strainer with MACS buffer (PBS, 2% FCS, 2mM EDTA (Sigma-Aldrich)). Stromal and hematopoietic cell fractions were enriched using MACS anti-CD45 microbeads (Miltenyi Biotec).

Cell characterization was performed by incubating single-cell suspensions in PBS containing 2% FCS and 2 mM EDTA for 20 min at 4 °C, using the indicated antibodies (Supplementary Table 1 ). Ghost Dye Violet 510 (LubioScience) was used to identify dead cells. Antigen-specific T cells were detected using PEconjugated s598 tetramers (Sanquin Reagents) after an incubation of 20 min at 37 °C. For measuring cytokine production, 10 6 cells were incubated with brefeldin A (5 μg/ml; Sigma) for 3.5 h at 37 °C. For intracellular staining, cells were surface stained and fixed using Cytofix/Cytoperm (BD Biosciences) for 20 min. Fixed cells were incubated at 4 °C for 40 min with monoclonal anti-GzmB (eBioscience) diluted in permeabilization buffer (eBioscience). Samples were analyzed by flow cytometry using a FACS Fortessa flow cytometer and the FACSDiva operating program. Data were analyzed using FlowJo software (Tree Star).

Cell sorting was performed on a BD FACSMelody™ cell sorter using BDChorus software. For discrimination between live and dead cells, Seven-aminoactinomycin D (Sigma-Aldrich) was added prior to sorting. Sorted cells were passed through the 10x Chromium (10x Genomics) system and cDNA libraries were generated according to the manufacturer's recommendations (Chromium Single Cell 3′ Reagent Kit (version 3 chemistry)). Sequencing of libraries was done using the NovaSeq 6000 Illumina sequencing system at the 

Murine lungs were perfused and fixed overnight at 4 °C in 4% paraformaldehyde (Merck Millipore) under agitation. Tissues were embedded and oriented in 4% low-melting agarose (Invitrogen) in PBS and cut into 60 to 80 um sections using a vibratome (VT-1200, Leica). Sections were blocked in PBS containing 10% FCS, 1 mg/ml anti-Fcγ receptor (BD Biosciences) and 0.1% Triton X-100 (Sigma). Sections were stained overnight with the indicated antibodies as indicated in Supplementary Table 1 . Unconjugated antibodies were detected with the following secondary antibody incubation for 1 hr at room temperature. Nuclei were stained with 4′-6-diamidino-2-phenylindole (DAPI) dihydrochloride (Life Technologies), and lung sections were mounted on glass microscopy slides using fluorescence mounting medium (Dako). Imaging was performed with an LSM 980 confocal microscope (Carl Zeiss) and microscopy data were processed with ZEN software (Zeiss) and

Imaris version 9 software (Bitplane).

Bone marrow was isolated from bones from IFNAR KO mice, LysM-Cre Ifnar fl/fl mice and littermate controls.

Murine bone marrow-derived macrophages (BMDMs) were generated by 7 days of culture with granulocytemonocyte colony-stimulating factor containing supernatant. After 7 days, 10 5 BMDMs were plated into 48 well plates and on the following day incubated with 0.01 MOI of MHV at 37 C. After 1 hour the virus was replaced with medium and supernatant was collected after 6 or 12 hours. MHV titers in the supernatant were determined by standard plaque assay.

For cytokine measurements, lung supernatant of day 2 infected mice and uninfected mice were used. IL1 levels were measured using the IL1 ELISA kit (Invitrogen) according to manufacturer instruction.

Absorbance was measured at 450nm on a Microplate reader (Tecan).

TNF- , MCP-1 and IL-6 cytokine levels were quantified using the Cytometric bead assay Mouse inflammation kit (BD Bioscience) as recommended by the manufacturer and measured by flow cytometry using a FACS Fortessa flow cytometer.

Vascular permeability assays were performed as per standardized protocol 36 . 40kDa FITC-Dextran (Invitrogen) was injected intravenously into mice. 1 hour later, mice were sacrificed and blood was collected by cardiac puncture. Serum was diluted 1:10 in PBS, and the fluorescence intensity was measured at 528 nm on a Microplate reader (Tecan).

Statistical analyses were performed with GraphPad Prism 8.0 with Mann-Whitney test and longitudinal comparison between different groups was performed with one or two-way analysis of variance (ANOVA) with Tukey's post-test or Kruskal Wallis test with Dunn's post-test. Statistical analyses are indicated in the figure legends. Statistical significance was defined as P < 0.05.

To systematically assess viral spread along the respiratory tract, we infected C57BL/6 (B6) mice with MHV via the intranasal (i.n.) route and measured viral titers between day 0 and day 6. All mice used for viral titer analysis showed presence of virus in at least one organ (Supplementary Figure 1A) . Intranasal infection of mice led to detectable viral titers in the NALT (Nasopharyngal-associated lymphoid tissue), the trachea and lung already 12 hours post infection (p.i.) ( Figure 1A ). Viral titers in the lungs peaked between 24 and 48 hours after the infection. By day 6 p.i. most mice had cleared the virus in the upper and lower respiratory tract. worse survival compared to infected Crelittermate controls ( Figure 1G ), while NK cell depletion was not observed to impact mouse survival ( Figure 1H ). As demonstrated previously 27 , the presence of CD8 + T cells was crucial for survival of mice, as CD8 + deficient β2-Microglobulin (β2M) mice were observed to succumb to the disease between day 8 and 10 p.i. (Figure 1I ). Taken together, pulmonary MHV infection was accompanied by increased inflammatory macrophage and NK cell infiltration, although type I interferon responsiveness in myeloid cells crucially was crucial to control MHV infection.

At present, insight into the inflammation-induced remodeling of coronavirus-infected lungs is primarily limited to sampling of bronchoalveolar lavage at later stages of viral infection, or to post-mortem tissue analysis. To define the early cellular and molecular changes in the lungs during MHV infection, we sought to examine the transcriptomic landscape of lung tissue from infected compared to naïve mice. We anticipated Figure 2D) .

Given the breadth of infected cell types, we sought to assess the transcriptional programs that were differentially regulated across cell types of MHV-infected lungs. Gene set enrichment analysis (GSEA) of signaling pathways enriched in infected compared to naïve mice revealed an upregulation of pathways associated with anti-viral defense mechanisms, such as regulation of innate immune response, pattern recognition receptor signaling or cytokine signaling ( Figure 2J ). While interferon stimulated gene (ISG)signatures were enhanced across infected cell types in MHV-infected lungs, macrophages and neutrophils cells harbored a strong ISG-signature ( Figure 2K ), while transcripts of pro-inflammatory cytokines were preferentially expressed by monocyte-derived macrophages ( Figure 2L ). In sum, although MHV was observed to readily infect hematopoietic, epithelial and stromal cell types, IFN-responsive and pro-inflammatory transcriptional programs were most pronounced in the monocyte-derived macrophages.

Since sensing of type I interferons by myeloid cells was observed to secure mouse survival following pulmonary MHV infection, we sought to determine the cellular and molecular transcriptional changes that Figure 3J ). In sum, impairing the sensing of type I interferon by myeloid cells was observed to lead to impaired induction of ISG-regulated antiviral programs at a single cell-level, resulting in decreased survival of infected host cells and impaired early viral control in lungs of infected mice.

To further determine the subset identity of macrophages from Ifnar-proficient and Ifnar-deficient LysM-Cretargeted cells we re-embedded monocyte-derived, interstitial and alveolar macrophage cell types from naïve, Ifnar-proficient and Ifnar-deficient mice. While macrophage subset identity was maintained in each condition, dimensional reduction plots revealed little overlap between cells from different gentoypes or from uninfected lungs ( Figure 4A ), suggesting a change in activation state. We used diffusion maps to plot macrophages along their activation trajectories, and found an interferon-dependent, infection-induced transcriptional reprograming of monocyte-derived macrophages ( Figure 4B ). While a modest transcriptional remodeling was observed in interstitial macrophages, too few alveolar macrophages were captured to assess the extent of inflammation-associated changes. Gene set enrichment analysis of Ifnar-proficient macrophages from MHVinfected mice revealed the upregulated expression of inflammatory and antiviral programs, including response to virus, response to interferon-beta, cytokine-mediated and NFB signaling compared to Ifnar-deficient macrophages ( Figure 4C ). Analysis of cytokine and chemokine expression profiles revealed an upregulation of IFN-stimulated chemokines such as Cxcl10, but also pro-inflammatory cytokines including Il6 and Tnf, especially by monocyte-derived macrophages ( Figure 4D ). Consistent with the observed enrichment of genes associated with cell chemotaxis in Ifnar-deficient macrophages ( Figure 3E ), we also observed the enhanced transcript expression of Il1b, the alarmins S100a8 and S100a9, as well as Ccl6 and Mif ( Figure 4D ). The contribution of macrophage-associated gene expression changes to the protein cytokine levels in the lungs was assessed using ELISAs and cytokine bead assays of lung supernatant from mice infected with MHV two days earlier. Consistent with transcriptome-level gene expression, the lungs of LysM-Cre Ifnar fl/fl mice showed a significant increase in activated IL-1 compared to naïve mice ( Figure 4E ). In contrast, lungs of conditionally Ifnar-deficient mice demonstrated significantly less MCP1 (encoded by Ccl2) and a trend towards less TNF compared to Ifnar-proficient mice ( Figure 4F, G) . Collectively, these data reveal a dynamic IFN-dependent, infection-associated transcriptional reprogramming of monocyte-derived macrophages, that in the absence of Ifnar compensates with increased IL1 expression and an altered chemotactic and alarmin profile.

Given the transcriptional and protein-level changes in inflammatory mediators in the lungs of Ifnar-proficient and Ifnar-deficient LysM-Cre-targeted mice, we next sought to investigate whether the altered inflammatory 10 Time 

Hosts and Sources of Endemic Human Coronaviruses

Coronavirus biology and replication: implications for SARS-CoV-2

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV

Single-cell landscape of immunological responses in patients with COVID-19

Heightened Innate Immune Responses in the Respiratory Tract of COVID-19

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Clinical and immunological features of severe and moderate coronavirus disease 2019

Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications

Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment

Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Presence of Genetic Variants Among Young Men With Severe COVID-19

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Control of coronavirus infection through plasmacytoid dendritic-cellderived type I interferon

A systems immunology approach to plasmacytoid dendritic cell function in cytopathic virus infections

Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology

Combined action of type I and type III interferon restricts initial replication of severe acute respiratory syndrome coronavirus in the lung but fails to inhibit systemic virus spread

Fibroblastic reticular cells regulate intestinal inflammation via IL-15-mediated control of group 1 ILCs

Virus-induced interferon alpha production by a dendritic cell subset in the absence of feedback signaling in vivo

Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection

Central Nervous System Stromal Cells Control Local CD8(+) T Cell Responses during Virus-Induced Neuroinflammation

Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines

Isolation and Purification of Epithelial and Endothelial Cells from Mouse Lung

Scater: pre-processing, quality control, normalization and visualization of single-cell RNA-seq data in R

Orchestrating single-cell analysis with Bioconductor

Comprehensive Integration of Single-Cell Data

clusterProfiler: an R package for comparing biological themes among gene clusters

Diffusion maps for high-dimensional single-cell analysis of differentiation data

destiny: diffusion maps for large-scale single-cell data in R

Vascular Permeability Assays In Vivo

A spatially restricted fibrotic niche in pulmonary fibrosis is sustained by M-CSF/M-CSFR signalling in monocyte-derived alveolar macrophages

Non-classical tissue monocytes and two functionally distinct populations of interstitial macrophages populate the mouse lung

Three Unique Interstitial Macrophages in the Murine Lung at Steady State

Capillary cell-type specialization in the alveolus

Interferon-Stimulated Genes: What Do They All Do?

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing